Retinol and Vitamin A Derivatives: The Hotlist Ceiling

Retinol is one of those ingredients that makes everyone nervous, and for good reason. It's genuinely effective, genuinely popular with customers, and genuinely capped in ways that catch formulators off guard, especially when they're layering it into a product that already has other actives competing for the same space on the label.

Why vitamin A derivatives sit on the Hotlist at all

Health Canada's Cosmetic Ingredient Hotlist exists to flag substances that are prohibited outright or restricted to a specific concentration, use, or context in cosmetics. Vitamin A and its derivatives, retinol itself along with related esters like retinyl palmitate, land in the restricted category rather than the prohibited one, meaning they are allowed, but only up to a ceiling concentration and often only in specific product types.

The reasoning tracks with what's broadly understood about vitamin A: it is genuinely bioactive at higher concentrations, and cosmetic use needs to stay clearly below the range where it starts behaving like a therapeutic drug rather than a cosmetic ingredient.

Where the line between cosmetic and drug actually sits

This is the part that trips people up most. A cosmetic is generally something that cleans, beautifies, or alters appearance without treating or preventing a disease or affecting the body's structure or function in a therapeutic sense. Push a vitamin A derivative's concentration high enough, or pair it with a treatment-style claim like "corrects photodamage" or "treats acne," and you have effectively described a drug, not a cosmetic, regardless of what's printed on the front of the bottle.

This mirrors the same logic that applies to other borderline categories: sunscreen, anti-acne, and antidandruff products are typically regulated as drugs rather than cosmetics because of what they claim to do, not because of some arbitrary label. Vitamin A derivatives sit in a similar gray zone specifically because concentration and claim both push the same direction at once.

Practical implications for formulators

• Check the current Hotlist entry directly before finalizing a formula. Concentration limits and the specific derivatives covered (retinol, retinyl palmitate, retinyl acetate, and others) can differ from each other, and Hotlist entries get updated, so treat any number you've heard secondhand as a starting point to verify, not a final answer.
• Watch your claims language as closely as your concentration. A vitamin A product marketed with cosmetic language, softens the appearance of fine lines, supports a smoother look, sits differently than one marketed with drug language, treats wrinkles, repairs sun damage. The concentration limit and the claim limit work together, not separately.
• Account for all vitamin A sources in a formula, not just the obvious one. If you're blending retinol with a plant extract or a supplier premix that itself contains a vitamin A derivative, the total concentration across all sources is what matters, not just the amount of pure retinol you added yourself.
• Recheck when you reformulate. Bumping a "retinol serum" from 0.3% to 0.5% because a customer asked for something stronger is exactly the kind of change that deserves a fresh look at where the current limit sits, not an assumption that your original filing still covers it.

A general shape of the restriction (verify current figures)

Consideration	What to check
Specific derivative used	Retinol, retinyl palmitate, and other esters may carry different treatment under the Hotlist
Current concentration ceiling	Confirm directly against the current Hotlist entry, these figures are the kind that get revised
Product category	Leave-on facial products draw more scrutiny than rinse-off
Claims made	Cosmetic-appropriate language versus therapeutic or drug-style claims
Total vitamin A load	Sum contributions from all ingredients and blends, not just the named active

Where to actually get the current number

The Hotlist is a living document, and vitamin A's exact figures are precisely the kind of detail worth pulling from Health Canada's current published list rather than relying on a number that might be a year or two stale by the time you read it. Treat any number you see cited elsewhere, including here, as a prompt to verify rather than a figure to formulate against directly.

This is exactly the kind of restriction Cosmetic Comply's screening step is built to catch, since it checks every ingredient's concentration against the current prohibited and restricted lists before a filing goes anywhere, with a compliance reviewer confirming the result rather than leaving it to a static reference table that might already be out of date.